StockWatch
·

INDO AMINES LTD.-$ Q2 FY27 Results

INDOAMINQ2 FY27 Results
Filing
Result:Weak· Market: Crashed#Margin squeeze
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue385.062.8%39.0%
Total Income388.973.4%38.0%
Expenditure377.2212.8%47.1%
PBT11.7571.8%54.1%
Net Profit8.6072.0%52.5%
OPM5.47%8.62pp6.07pp
NPM2.21%5.97pp4.21pp
EPS1.2370.6%50.8%
View full financials

Chemicals sector core metric of adjusted PAT fell 52.5% YoY on sharp, purely operational margin compression (OPM 11.5%→5.5%) from rising raw-material costs, despite strong 39% revenue growth.

Q2 FY-2027 RESULTS · INDOAMIN

Indo Amines Q2 FY27: Consolidated PAT Falls 52.5% YoY to ₹8.6 Cr on Margin Squeeze

PAT -52.52% YoY · revenue +38.99% · margins compressing

06 Nov 2026 · 3 min read
Revenue

₹385.06 Cr

+38.99% YoY

PAT (consolidated)

₹8.6 Cr

-52.52% YoY

Net margin

2.21%

-4.2pp YoY

EPS

₹1.23

Indo Amines' consolidated Q2 FY27 (quarter ended September 2026) revenue from operations grew 39.0% YoY and 2.8% QoQ to ₹385.06 Cr, but consolidated PAT fell 52.5% YoY to ₹8.60 Cr (from ₹18.11 Cr) and dropped 72.0% QoQ (from ₹30.76 Cr) as margins compressed sharply. Net profit margin fell to 2.21% from 6.42% YoY and 8.18% QoQ; operating margin fell to roughly 5.5% from 11.54% YoY and 14.09% QoQ. There were no exceptional or one-off items in the current quarter or in either comparison quarter, so the decline is purely operational rather than a base-effect distortion — raw and adjusted YoY PAT growth are identical, at -52.5%.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹385.06 Cr+2.8%+39%
Expenses₹377.22 Cr+12.8%+47.1%
PAT₹8.6 Cr-72.05%-52.52%
Net margin2.21%-6pp-4.2pp
EPS₹1.23-70.6%-50.8%

The squeeze traces to raw material costs: Cost of Materials Consumed rose to about 76.2% of revenue from operations this quarter, up from roughly 69.4% in Q1 FY27 and 69.9% in the year-ago quarter, eating into margins even as volumes/pricing drove topline growth. Standalone results are directionally consistent — PAT of ₹6.83 Cr on revenue of ₹380.30 Cr (EPS ₹0.98) versus consolidated PAT of ₹8.60 Cr (EPS ₹1.23) — with subsidiaries (Indo Specialty Chemicals and the US/Europe/Malaysia/China units) adding to both revenue and profit without changing the margin story. The company has no formal guidance on record with us, and none turned up in public filings, so there is no guidance verdict to render; analyst coverage is thin (only two trackers on consensus platforms, neither has submitted an estimate), so the street comparison is unknown rather than a beat or miss. Operationally, a GST inspection at the registered office concluded on October 29, 2026 with no material impact, and the Mahad facility received conditional permission to restart on October 17, 2026; separately, GPCB's earlier closure directions on the Gujarat (Savli, Vadodara) plant were revoked in August 2026 with no material financial impact this quarter, per the filing's own notes. None of these disclosed developments explain the margin compression, which is squarely a raw-material-cost story; no management press release was available to cross-check against these numbers.

₹
114.85127.76140.67153.59166.5122.308-0308-2509-1710-1211-0411-06Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹122.3, down 22.3% over the past month of trading.

₹ Cr
011.4822.9634.4528.84Q1 FY26rev ₹288 Cr18.11Q2 FY26rev ₹277 Cr11.87Q3 FY26rev ₹277 Cr20.51Q4 FY26rev ₹318 Cr30.76Q1 FY27rev ₹375 Cr8.6Q2 FY27rev ₹385 Cr
Quarterly consolidated PAT, ₹ Crore

For context: revenue is at a 6-quarter high.

  • W1

    Whether Cost of Materials Consumed (currently ~76.2% of revenue) normalizes toward the ~69-70% band seen in Q1 FY27/Q2 FY26 — the key margin-recovery marker for Q3 FY27.

  • W2

    Full resumption status of the Mahad facility beyond the conditional restart permission granted October 17, 2026.

  • W3

    Confirmation of no follow-up demand/action following the GST inspection the company says concluded October 29, 2026 with no material impact.

Figures reported in ₹ Lakh (converted to ₹ Cr); no exceptional/extraordinary items in current or either comparison quarter; auditor's standalone review report text misdates the period as 'September 2025' (clerical typo — the statement tables, balance sheet and board outcome letter all confirm quarter ended 30 Sept 2026).

Informational and educational content only. Not investment advice.